Opendata, web and dolomites

Epi4MS SIGNED

Targeting the epigenome: towards a better understanding of disease pathogenesis and novel therapeutic strategies in Multiple Sclerosis

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Epi4MS project word cloud

Explore the words cloud of the Epi4MS project. It provides you a very rough idea of what is the project "Epi4MS" about.

epigenetic    medicine    sclerosis    spearheading    adults    mechanisms    therapies    immune    inflammatory    mediated    extensive    cutting    alternative    sustained    young    molecular    preventing    utilize    disability    unknown    point    formulated    reversible    facets    correcting    corrected    self    paradigm    discovery    code    edge    environmental    unpredictable    capture    stage    triggered    gene    diseases    chronic    animal    prioritize    reversal    complement    insights    synergistic    combined    dna    expression    multiple    aberrant    gain    stable    exact    innovative    treating    models    pathogenesis    epigenome    progressive    pathogenic    inducing    genetically    shift    rational    precision    powerful    marks    causal    biobank    provides    genetic    methylation    regulate    incurable    dissect    cells    therapeutic    disease    added    screens    vivo    ms    editing    regulators    vitro    individuals    throughput    functional    unbiased    laboratory    starting    aggressive    predisposed    modulating    nature    organ    modifiable    mediate   

Project "Epi4MS" data sheet

The following table provides information about the project.

Coordinator
KAROLINSKA INSTITUTET 

Organization address
address: Nobels Vag 5
city: STOCKHOLM
postcode: 17177
website: www.ki.se

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Sweden [SE]
 Total cost 1˙998˙798 €
 EC max contribution 1˙998˙798 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2018-COG
 Funding Scheme ERC-COG
 Starting year 2019
 Duration (year-month-day) from 2019-06-01   to  2024-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    KAROLINSKA INSTITUTET SE (STOCKHOLM) coordinator 1˙998˙798.00

Map

 Project objective

Multiple Sclerosis (MS) is a leading cause of unpredictable and incurable progressive disability in young adults. Although the exact cause remains unknown, this immune-mediated disease is likely triggered by environmental factors in genetically predisposed individuals. I propose that epigenetic mechanisms, which regulate gene expression without affecting the genetic code, mediate the processes that cause MS and that aberrant epigenetic states can be corrected, spearheading the development of alternative therapies. We will exploit the stable and reversible nature of epigenetic marks, in particular DNA methylation, to gain insights into the novel modifiable disease mechanisms by studying the target organ in a way that has not been possible before. This highly ambitious project comprises three synergistic facets formulated in specific aims to: (i) identify epigenetic states that characterize the pathogenesis of MS, (ii) prioritize functional epigenetic states using high-throughput epigenome-screens, and (iii) develop novel approaches for precision medicine based on correcting causal epigenetic states. Our unique MS biobank combined with cutting-edge methodologies to capture pathogenic cells and measure their functional states provides a rational starting point to identify MS targets. I will complement this approach with studies of the functional impact of MS targets using innovative in vitro screens, with the added value of unbiased discovery of robust regulators of specific MS pathways. Finally, my laboratory has extensive experience with animal models of MS and I will utilize these powerful systems to dissect molecular mechanisms of MS targets and test the therapeutic potential of targeted epigenome editing in vivo. Our findings will set the stage for a paradigm-shift in studying and treating chronic inflammatory diseases based on preventing and modulating aggressive immune responses by inducing self-sustained reversal of aberrant epigenetic states.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EPI4MS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EPI4MS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

ENUF (2019)

Evaluation of Novel Ultra-Fast selective III-V Epitaxy

Read More  

Diverge (2019)

Generation of ultra-deep libraries of transcriptional activators for gene therapy

Read More  

PonD (2019)

Particles-on-Demand for Multiscale Fluid Dynamics

Read More